Status:
COMPLETED
Enhanced, Personalized and Integrated Care for Infection Management at the Point-Of-Care
Lead Sponsor:
Imperial College London
Conditions:
Antibiotic Resistant Infection
Infection
Eligibility:
All Genders
18+ years
Brief Summary
Antimicrobials (drugs that kill or stop the growth of microorganisms including bacteria, thereby treating infections) commonly used to treat patients with infections are becoming less effective over t...
Detailed Description
Prototype software to achieve this has been developed through collaboration between healthcare professionals and biomedical engineers. This prototype software (run on a mobile device) retrieves patien...
Eligibility Criteria
Inclusion
- (i) healthcare professionals for evaluation phases: Have read the PIL and consent to participate in the study
- (ii) patients for whom the clinician chooses to use the POC DSS as a resource when prescribing antimicrobials: Adult patients \> 18 years old Being managed for infection outside of the critical care setting in Imperial College Healthcare NHS Trust Deemed appropriate for management with POC DSS by attending physician Prescribed antimicrobial agents outside of the critical care setting in last 5 days
- (iii) Prescriber / healthcare professional for using POC DSS: Trained Healthcare Professional Working within wards under assessment Deemed suitable for recruitment by senior member of their team
Exclusion
- (i) healthcare professionals: Do not wish to participate in the study Working across wards which is acting as a control ward Deemed no suitable for recruitment by a senior member of their team Non-permanent member of the Trust Information governance training not up-to-date
- (ii) patients recruits Critical care patients Paediatric patients \< 18 years old Deemed not suitable for management using POC DSS by attending physician On palliative care, end of life pathway Prisoners / young offenders in custody of HM Prison Service Involved in current research or have recently been involved in any research prior to recruitment (last 3 months)
Key Trial Info
Start Date :
February 28 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 8 2019
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04013737
Start Date
February 28 2017
End Date
August 8 2019
Last Update
August 31 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College London
London, United Kingdom, W12 0NN